Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2004 Dec;70(12):7173–7178. doi: 10.1128/AEM.70.12.7173-7178.2004

Prevalence and Characterization of Shiga Toxin-Producing Escherichia coli in Swine Feces Recovered in the National Animal Health Monitoring System's Swine 2000 Study

Pina M Fratamico 1,*, Lori K Bagi 1, Eric J Bush 2, Barbara T Solow 1,
PMCID: PMC535163  PMID: 15574914

Abstract

A study was conducted to determine the prevalence of Shiga toxin-producing Escherichia coli (STEC) in swine feces in the United States as part of the National Animal Health Monitoring System's Swine 2000 study. Fecal samples collected from swine operations from 13 of the top 17 swine-producing states were tested for the presence of STEC. After enrichment of swine fecal samples in tryptic soy broth, the samples were tested for the presence of stx1 and stx2 by use of the TaqMan E. coli STX1 and STX2 PCR assays. Enrichments of samples positive for stx1 and/or stx2 were plated, and colony hybridization was performed using digoxigenin-labeled probes complementary to the stx1 and stx2 genes. Positive colonies were picked and confirmed by PCR for the presence of the stx1, stx2, or stx2e genes, and the isolates were serotyped. Out of 687 fecal samples tested using the TaqMan assays, 70% (484 of 687) were positive for Shiga toxin genes, and 54% (370 of 687), 64% (436 of 687), and 38% (261 of 687) were positive for stx1, stx2, and both toxin genes, respectively. Out of 219 isolates that were characterized, 29 (13%) produced stx1, 14 (6%) produced stx2, and 176 (80%) produced stx2e. Twenty-three fecal samples contained at least two STEC strains that had different serotypes but that had the same toxin genes or included a strain that possessed stx1 in addition to a strain that possessed stx2 or stx2e. The STEC isolates belonged to various serogroups, including O2, O5, O7, O8, O9, OX10, O11, O15, OX18, O20, O57, O65, O68, O69, O78, O91, O96, O100, O101, O120, O121, O152, O159, O160, O163, and O untypeable. It is noteworthy that no isolates of serogroup O157 were recovered. Results of this study indicate that swine in the United States harbor STEC that can potentially cause human illness.


Shiga toxin-producing Escherichia coli (STEC), also known as verotoxin-producing E. coli (VTEC), comprises a serologically diverse group of pathogens that cause disease in humans and animals (4, 25, 27). Enterohemorrhagic E. coli O157:H7, the most prominent STEC, has caused numerous outbreaks of food-borne disease, hemorrhagic colitis, and hemolytic-uremic syndrome (HUS) worldwide (32, 39). However, over 200 non-O157 STEC serotypes have been identified, and over 100 strains have been associated with human illness (38, 51). In Australia, Argentina, and many European countries, infection with non-O157 STEC serotypes is common and may account for the majority of the cases of HUS (38). The common feature of STEC strains is the production of Shiga toxin 1 (Stx1) and/or Shiga toxin 2 (Stx2) or variants of Stx1 (Stx1c and Stx1d) or Stx2 (Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g) (11, 20, 30, 46). The STEC strains that cause edema disease in swine produce the Stx2e variant (13). Strains harboring stx2e, however, have also been isolated from patients with diarrhea and HUS (35, 44, 49).

A number of studies have demonstrated that animals, including cows, sheep, goats, and pigs, are reservoirs for different STEC strains, including serogroups that have been associated with human illness (3, 5, 12, 18, 23, 26). Botteldoorn and coworkers (10) isolated STEC that possessed the stx2e variant gene from 56 of 177 (32%) pig rectal swabs and reported that 14 and 5% of these isolates were positive for the eaeA and hlyA virulence genes, respectively. No isolates, however, carried a combination of all three genes. On the contrary, Rios et al. (45) isolated enterohemorrhagic STEC serogroups O26 and O111 from pig intestinal contents, and the strains harbored virulence genes with profiles indicative of potential human pathogens (stx1, stx2, eae, and hly or stx1, stx2, and eae), suggesting that pigs may be an important animal reservoir for these organisms. Although the presence of STEC in swine has been investigated to some extent to determine if pigs are an important animal reservoir for these organisms, comprehensive surveys of swine for STEC are lacking in the United States.

Unlike E. coli O157:H7 strains, which generally are sorbitol and β-glucuronidase negative, the non-O157 STEC strains do not have identifiable biochemical markers to facilitate screening for and identification of these pathogens. Furthermore, since there are no phenotypic markers shared by all non-O157 STEC strains, except for the production of Shiga toxins, that can be utilized to distinguish them from nonpathogenic E. coli strains, detection and identification of these pathogens are difficult. Detection of non-O157 STEC serotypes requires testing for the Shiga toxins by immunologic or toxin receptor-mediated enzyme-linked immunosorbent assays, tissue culture assays, and/or PCR or DNA hybridization techniques targeting the Shiga toxin genes (2, 25, 47, 50). Fluorogenic 5′ nuclease PCR assays (TaqMan) allow automated PCR amplification, detection, and analysis of pathogens and have been used to detect food-borne pathogens, including STEC, in food, animal feces, and other types of samples (8, 24, 48).

Two main objectives of the National Animal Health Monitoring System (NAHMS) Swine 2000, a national study established by the U.S. Department of Agriculture's (USDA's) Animal and Plant Health Inspection Service, were to measure the degree to which food-borne pathogens are found in finisher pigs and to identify potential control factors to reduce the public health risk from these pathogens (49a). Although human illness associated with swine STEC is uncommon, outbreaks and cases of illness due to different STEC serotypes have occurred in recent years in the United States and worldwide. Thus, the objectives of the present study were (i) to determine the prevalence of STEC in swine in the United States and (ii) to determine the serotypes and types of Shiga toxin genes in the swine STEC isolates.

MATERIALS AND METHODS

Study design and sample collection.

A report published by the USDA's Animal and Plant Health Inspection Service and Veterinary Services in August 2001 provides a complete description of the NAHMS 2000 study design (49a). Briefly, fecal samples were obtained from a subset of sites distributed across swine operations from the top 17 pork-producing states, representing 94% of producers in the United States with 100 or more pigs as of 1 December 1999. Samples were collected over a period of 25 weeks during the months from September 2000 to March 2001. Up to 50 fresh fecal samples were obtained from the pen floors of late-finisher pigs (over 20 weeks of age). In addition, up to 10 floor samples were obtained from cull sows (within 10 days of slaughter) when available. Samples were placed in Whirl-Pak bags (Nasco, Modesto, Calif.) and shipped overnight in Styrofoam coolers containing freezer packs to the Richard B. Russell Agricultural Research Center in Athens, Ga. Samples were then processed and shipped overnight in coolers to the Eastern Regional Research Center in Wyndmoor, Pa., for testing. A total of 687 fecal samples were tested for the presence of STEC.

Enrichment of fecal samples.

Ten grams of each fecal sample was mixed with 100 ml of tryptic soy broth (TSB; Becton Dickinson, Sparks, Md.) in Bagfilter bags (Spiral Biotech, Inc., Norwood, Mass.) and subjected to enrichment at 37°C for 12 h with shaking at 100 rpm. A subset of samples was plated and processed immediately after enrichment as described below; however, the rest of the samples that could not be processed immediately were frozen at −80°C with 20% glycerol and then thawed and processed later. One-half milliliter of the thawed enrichments was added to 2.5 ml of TSB, which was then incubated at 37°C for 4 h prior to plating onto Luria-Bertani (LB) agar (Becton Dickinson).

DNA extraction and TaqMan PCR.

One milliliter of each enrichment sample was subjected to DNA extraction with PrepMan sample preparation reagent (Applied Biosystems, Foster City, Calif.) according to the manufacturer's instructions with the following modifications. Briefly, a 1-ml sample was centrifuged at 16,000 × g for 2 min, and the pellet was washed twice with sterile water and then resuspended in 200 μl of PrepMan reagent. The sample was then heated at 100°C for 10 min and centrifuged at 16,000 × g for 2 min. The supernatant (100 μl) was collected, and 5 μl of each sample was used for the TaqMan PCR assays. The TaqMan E. coli STX1 and STX2 detection kits (Applied Biosystems), targeting the stx1 and stx2 genes, respectively, were used according to the manufacturer's instructions to detect the presence of STEC in the fecal samples. The assay was performed in a 96-well format by use of a GeneAmp 9600 PCR system instrument (Applied Biosystems), and PCR products were detected using an ABI Prism 7200 sequence detector with Sequence Detector software (version 1.6.3).

Colony hybridization and confirmation of isolates by multiplex PCR using primers targeting stx1, stx2, and stx2e.

Diluted portions (100 μl of 1:1,000 and 1:10,000 dilutions) of the enrichment samples that were positive for stx1 and stx2 by the TaqMan assays were plated onto LB agar, and the plates were incubated at 37°C for 20 h. Hybond-N+ membranes (Amersham Pharmacia Biotech, Piscataway, N.J.) were marked for orientation, and colony lifts were performed with the plates having ca. 100 to 200 colonies. Following denaturation and neutralization of the membranes, performed according to instructions in the PCR DIG probe synthesis kit user's manual (Roche Diagnostics GmbH, Indianapolis, Ind.), the DNA was cross-linked to the membranes by use of a Stratalinker 2400 instrument (Stratagene, La Jolla, Calif.). The digoxigenin (DIG)-labeled stx1 and stx2 DNA probes were prepared with the stx1 and stx2 PCR products (see below) by using the PCR DIG probe synthesis kit (Roche Diagnostics GmbH) according to the manufacturer's instructions. The membranes were placed into hybridization bottles and subjected to prehybridization for 1 h, followed by hybridization with a mixture of the two DIG-labeled probes (12 ml of hybridization solution; four membranes/tube) according to the instructions for the DIG nucleic acid detection kit (Roche Diagnostics GmbH). After color development, colonies that aligned with spots on the membrane were picked and tested by multiplex PCR with primers for the stx1 and stx2 genes. Up to four colonies were picked and tested per plate. Colonies were suspended in 40 μl of sterile water and heated at 99°C for 10 min in a GeneAmp PCR System 9600 thermal cycler (Applied Biosystems) to lyse the bacteria. Oligonucleotide primer sequences used for amplification of regions in the stx1 and stx2 genes, yielding products of 210 and 484 bp, respectively, were as follows: SLT1F, 5′-TGTAACTGGAAAGGTGGAGTATACA-3′; SLT1R, 5′-GCTATTCTGAGTCAACGAAAAATAAC-3′; SLT2F, 5′-GTTTTTCTTCGGTATCCTATTCC-3′; and SLT2R, 5′-GATGCATCTCTGGTCATTGTATTAC-3′ (34). The PCR reagent system kit (Invitrogen, Carlsbad, Calif.) was employed to prepare the PCR mixture, which consisted of 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 3.0 mM MgCl2, 0.1% Triton X-100, a 400 μM concentration of each of the four deoxynucleotide triphosphates, 2.5 U of Taq DNA polymerase, a 0.5 μM concentration of each of the primers, and 5 μl of template DNA. The cycling protocol, using the primers for stx1 and stx2, consisted of denaturation at 94°C for 2 min; 35 cycles at 94°C for 20 s, 57°C for 1 min, and 72°C for 1 min; and a final extension at 72°C for 10 min. Primers for amplification of a region of the stx2e gene (a 230-bp product) were VT2e-A and VT2e-B, whose sequences were 5′-CCTTAACTAAAAGGAATATA-3′ and 5′-CTGGTGGTGTATGATTAATA-3′, respectively (6). The cycling protocol consisted of 94°C for 3 min; 30 cycles at 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and a final extension at 72°C for 10 min. Isolates that produced stx1, stx2, or stx2e were stored at −70°C in TSB with 20% glycerol.

Serotyping of isolates.

Isolates were sent to the Gastroenteric Disease Center at The Pennsylvania State University (University Park, Pa.) for serotyping.

RESULTS AND DISCUSSION

Prevalence of STEC in swine fecal samples.

Out of a total of 687 swine fecal samples tested for the presence of stx1 and stx2 by the TaqMan STX1 and STX2 PCR assays, 484 (70%) samples were positive for stx1, stx2, or both toxin genes. Experiments using fecal samples artificially inoculated with E. coli O157:H7 strains that harbored both stx1 and stx2 (a mixture of strains 933 and 380-94) showed that the detection limit of the TaqMan assays for both stx1 and stx2 was ca. 103 CFU/10 g of feces. Up to four colonies were picked from plates that were positive by DNA hybridization (from 196 different fecal samples). Thus, isolates were obtained from ca. 40% (196 of 484) of the stx1- or stx2-positive samples. This result is in agreement with the results of Botteldoorn et al. (10), who were able to isolate a STEC strain in only one-third of the PCR-positive samples from pigs. These authors suggested that this rate of isolation was due the presence of both high levels of background microflora and low levels of STEC in the pig fecal samples. In the present study, a nonselective enrichment medium (TSB) was used to allow recovery of stressed or injured STEC in the fecal samples. The use of a selective agar rather than LB agar might have resulted in higher recovery rates from samples with low levels of STEC, since selective agar may have prevented the growth of a portion of the non-STEC bacteria; thus, lower dilutions of the enrichments could possibly have been plated on a selective agar. Furthermore, a nonselective enrichment in TSB followed by a selective enrichment could also have been performed, and additional STEC isolates may also have been obtained if colony lifts and hybridizations had been performed on several plates obtained from the same enrichment sample. Analysis of colonies from the 196 DNA hybridization-positive samples showed that 23 of the 196 samples from which STEC strains were isolated contained at least two different strains of different serogroups. Thus, the data in Table 1 show results for 219 STEC isolates, i.e., one isolate from each of 173 fecal samples and two isolates from each of 23 samples.

TABLE 1.

Detection of Shiga toxin genes by PCR in swine fecal samples and characterization of the swine STEC isolates

Kita State Date (mo/day/yr) TaqMan PCR results
PCR results
E. coli serotyping resultsd
Total no. of samples tested No. of samples positive for:
Total no. of isolatesb tested No. of isolatesc positive for:
O antigen H antigen
stx1 stx2 stx1 stx2 stx2e
6 Ill. 9/6/2000 60 17 12 3 0 0 3 O8, O120 H(−), H9
2 Nebr. 9/18/2000 50 37 41 18 0 0 18 O120, O8, O121, O65, O2, O78 H44, H(−)
30 Iowa 9/18/2000 10 8 2 3 1 0 2 O120, O91 H(−)
35 Minn. 9/19/2000 50 7 9 31 0 4 27 O(−), O7, O8, O8w, O9w, O11w, O20, OX10, O96 H(−), H(+), H3, H5, H9, H19, H25, H30, H42
14e Mich. 9/20/2000 28 15 12 7 2 0 5 O(−), O8, O20 H19, H42, H51
34 Minn. 9/20/2000 24 17 22 14 0 0 14 O8 H(−), H9, H19, H20
20e Iowa 10/2/2000 19 15 15 3 1 2 0 O159, O152 H(−), H4w
21 Iowa 10/2/2000 21 18 14 10 1 2 7 O(−), O15, O8, O100w, O121, O159, O171, O69, O5 H(−), H9, H10, H17, H26, H30, H34
33 Ind. 10/2/2000 18 17 13 4 0 0 4 O8, O(−) H19, H20, H42
37 S.D. 10/2/2000 9 9 9 5 5 0 0 O91 H(−), H12
61e Nebr. 10/16/2000 45 31 41 33 1 2 30 O(−), O8, O8w, O9, O20, O91, O100, O100w H(−), H9, H17, H30, H34, H44
26 Iowa 10/17/2000 39 8 8 3 3 0 0 O(−), O163, OX18 H(−), H51, H24, H56
78 Iowa 10/30/2000 25 13 19 12 4 0 8 O(−), O91, O8 H(−)
52 Ark. 10/30/2000 25 19 24 0 0 0 0
44e Minn. 10/31/2000 20 9 19 16 1 0 15 O(−), O8, O160, O20 H(−)
59 N.C. 10/31/2000 20 0 17 3 0 0 3 O(−), O100w H30, H(−)
74 Ind. 10/31/2000 20 4 20 5 0 0 5 O(−), O8 H(−)
84 N.C. 11/28/2000 32 0 31 6 0 0 6 O121, O159 H(−), H10
87 Iowa 11/27/2000 18 0 7 4 0 0 4 O(−), O8, O120 H(−), H9
142 Iowa 2/5/2001 37 33 10 3 3 0 0 O163 H(−), H41, H51
132 Kans. 2/6/2001 20 20 5 1 0 1 0 O159 H4
137 Minn. 2/6/2001 25 23 15 10 0 0 10 O(−), O8, O68, O101 H(−), H20, H37
66 Iowa 10/16/2000 5 5 5 3 3 0 0 A, O91 H(−), H14
53e Wis. 10/16/2000 7 1 6 9 2 1 6 O(−), O8, OX18, O57w, O91, O100, O120 H14, H17, H23, H30
150 Iowa 3/20/2001 16 14 16 4 0 1 3 O8, O57w, O121 H(−)
151 Iowa 3/20/2001 14 7 14 0 0 0 0
152 Iowa 3/20/2001 15 12 15 3 0 1 2 O(−), O8, O20 H(−), H4w
102 Iowa 3/19/2001 15 11 15 6 2 0 4 O8, OX18, O121, O163 H(−)
Total 687 370 436 219 29 14 176
a

Samples collected from one location on one day comprised one kit.

b

Total number of isolates obtained from different stx1- and/or stx2-positive fecal samples from each kit.

c

Number of isolates shown to possess stx1, stx2, or stx2e by PCR targeting those genes.

d

(−), no reaction with standard antisera; (+), fliC gene was amplified by PCR, but no agglutination reaction occurred with any of the H typing antisera; A, autoagglutination; w, weak reaction.

e

Kit contained samples that had an isolate harboring stx1 and an isolate harboring stx2 or stx2e.

Several studies have examined the prevalence of STEC in swine. Parma et al. (42) isolated enterotoxigenic E. coli (ETEC) and VTEC from rectal swabs of healthy pigs and pigs with diarrhea over a period of 5 years in Argentina. The ETEC and VTEC strains were isolated from 5% of the rectal swabs obtained from 223 pigs. Isolated colonies were tested by PCR for Shiga toxin genes and genes associated with ETEC. The isolates that harbored stx2e, all recovered from pigs that showed delayed growth or that had diarrhea or edema disease, belonged to serogroup O8, O138, or O139 or were untypeable. A number of isolates that possessed stx2e also had additional virulence genes, including the LTI, STIa, and STb genes. Botteldoorn et al. (10) isolated E. coli strains with the stx2e variant from 31% of pig rectal samples, but no strains had stx1. Additional studies have shown that the incidence of STEC in pigs may be as high as 69% (9, 45). The strains isolated from pigs had toxin profiles similar to those of strains from humans and food (45) and included strains that possessed the stx1 and stx2 genes; however, it was not determined if the strains that harbored stx2 actually possessed the stx2e variant. A study conducted in northern Italy showed that STEC strains were present in 7.8% (19 of 242) of fecal samples obtained from healthy pigs (12). Fecal samples were enriched in Trypticase soy broth overnight, and the supernatants were tested by the Vero cell assay for the presence of Shiga toxins. Five isolates belonging to serogroups O101 and O8 were recovered from Vero cell assay-positive samples. These studies show that the incidence of STEC in swine varies and that the variation in methods employed for detection and isolation of STEC may be a factor contributing to differences among measurements of prevalence. Furthermore, the prevalence of E. coli O157:H7 and non-O157 STEC in animals may be lower in the winter months. Thus, since the fecal samples tested in the present study were collected during the months of September through March, the prevalence of STEC may have been somewhat lower than if samples had been collected during the summer months.

STEC serogroups isolated from swine fecal samples.

A number of STEC serogroups have been isolated from pigs, including O2, O5, O7, O8, O9, O15, O65, O91, O101, O120, O121, and O163 (12, 15, 22, 23, 29, 36). All of these serogroups and several others were isolated from pig fecal samples examined in the present study (Tables 1 and 2). Studies have shown that STEC can be isolated, often at similar frequencies, from healthy weaned pigs and pigs with diarrhea or edema disease (15, 22, 23, 36, 41). Feces tested in the present study were obtained from cull sows and pigs that were apparently healthy and that did not have diarrhea or symptoms of edema disease. The most prevalent E. coli serogroups isolated from pigs with edema disease and postweaning diarrhea are O138, O139, O141, and O149 (21, 36, 40), which were not isolated from swine feces examined in the present study (Tables 1 and 2). With the exception of several “rough ” STEC strains, all isolates obtained from pigs with edema disease or diarrhea in Denmark and several other European countries belonged to serogroup O139 (1). Interestingly, all of the E. coli O139 isolates that harbored stx2e were grouped into one cluster by pulsed-field gel electrophoresis, indicating the potential spread of one clone among the pigs. A similar study also showed that E. coli O139 was the predominant STEC strain isolated from pigs with edema disease (14).

TABLE 2.

E. coli serotypes isolated from swine fecal samples possessing the stx1, stx2, or stx2e genes

Serotype(s) of isolates No. of isolates possessinga:
stx1 stx2 stx2e
O(−):H(−) 10
O(−):H(4) 1
O(−):H9 1
O(−):H20 1
O(−):H30 1 11
O(−):H34 1
O(−):H42 2
O(−):H51 1
O(−):H51, H24b 1
O2:H44 1
O5:H17 1
O7:H(+)c 1
O8:H(−) 2 35
O8:H3 1
O8:H9 1 20
O8:H17 2
O8:H19 8
O8:H20 3
O8:H20, H37b 3
O9:H9 1
O9:H17 2
O9:H19 1
O11:H25 1
O15:H(−) 1
O20:H(−) 3
O20:H19 1
O20:H30 5
O20:H42 3
O57:H(−) 1
O57:H14 1
O65:H(−) 1
O68:H(−) 1
O69:H26 2
O78:H(−) 1
O91:H(−) 10
O91:H12 2
O91:H14 2
O91:H44 2
O96:H5 1
O100:H(−) 1
O100:H30 1 20
O101:H(−) 4
O120:H(−) 15
O120:H30 1
O121:H(−) 1 2
O121:H10 7
O152:H(−) 1
O159:H(−) 1 1
O159:H4 2
O159:H34 1
O160:H(−) 1
O163:H(−) 4
O163:H41, H51b 1
OX10:H(−) 1
OX18:H(−) 1
OX18:H23, H24b 1
OX18:H24, H56b 1
A:H(−) 1
Total 29 14 176
a

Number of strains of the E. coli serotype in which a specific toxin gene was found.

b

Agglutination occurred with two different H-antisera, as indicated.

c

(+), fliC gene amplified by PCR, but no agglutination reactions observed with any of the H typing antisera.

Shiga toxin genes in swine STEC.

In the present study, multiple isolates from a single positive sample typically displayed the same phenotype; however, six fecal samples contained a strain that harbored the stx1 gene in addition to a strain that harbored stx2 or stx2e. The samples were the following: (i) kit 14, sample 35, E. coli O8:H19 (stx2e) and O20:H19 (stx1); (ii) kit 20, sample 39, E. coli O159:H(−) (stx2) and O152:H(−) (stx1); (iii) kit 44, sample 37, E. coli O8:H(−) (stx2e) and O160:H(−) (stx1); (iv) kit 53, sample 2, E. coli O8:H17 (stx2e) and OX18:H23 (stx1); (v) kit 53, sample 6, E. coli O(−):H30 (stx2e) and O91:H14 (stx1); and (vi) kit 61, sample 45, E. coli O100:H30 (stx2e) and O91:H(−) (stx1). Strains of E. coli serogroup O91, possessing different H types, have been isolated from healthy pigs and pigs with diarrhea (5, 15, 23). Many of the E. coli O91 strains produced stx1. In the present study, 16 isolates belonged to serogroup O91 (Table 2). Fourteen isolates [belonging to serogroups O91:H(−), O91:H12, and O91:H14] harbored stx1, and two isolates (serogroup O91:H44) harbored stx2e. E. coli O157:H7 has been isolated from swine feces and intact-colon fecal samples from several countries, including the United States, Japan, and Norway (17, 26, 37); however, E. coli O157:H7 was not isolated from swine feces examined in the present study, nor was this serotype isolated in a separate project, also part of the NAHMS Swine 2000 study, that specifically targeted E. coli O157:H7 (I. Feder, J. T. Gray, R. A. Pearce, E. Bush, P. Fratamico, F. M. Wallace, A. Porto, P. Fedorka-Cray, R. Perrine, R. Dudley, and J. B. Luchansky, Abstr. Int. Assoc. Food Prot. Annu. Meet., abstr. P120, 2002).

Out of a total of 687 fecal samples tested, 54% (370 of 687), 64% (436 of 687), and 38% (261 of 687) were positive for stx1, stx2, and both toxin genes, respectively, by PCR. Twenty-nine (13%), 14 (6%), and 176 (80%) of the 219 isolates obtained from the PCR-positive samples possessed the stx1, stx2, and stx2e genes, respectively (Table 2). The TaqMan STX1 and STX2 PCR assays are rapid, sensitive, and able to differentiate between stx1 and stx2; however, the assays cannot differentiate between stx2 and stx2e. Primers targeting stx2e were subsequently used to determine if strains harboring stx2 (a 484-bp product) possessed the stx2e variant (a 230-bp product), which is found in a large proportion of STEC strains from healthy pigs, as well as from pigs with postweaning diarrhea and edema disease (15, 40, 41). In the present study, a large proportion of the swine STEC strains harbored stx2e. Although Stx2e-producing STEC strains have caused diarrhea and HUS in humans (35, 44, 49), swine STEC strains (harboring stx2e) are more likely to cause disease in swine. Osek (41) isolated 76 and 2 STEC strains from pigs with diarrhea and healthy pigs, respectively; all strains harbored the stx2e variant. A study in Brazil found that 69% (99 of 144) of the E. coli strains isolated from pigs with edema disease possessed stx2e (14). Apparently, swine-infecting E. coli strains that produce Shiga toxins compose a heterogeneous group. Many also possess genes encoding the F18 fimbriae, hemolysins, stable toxin or labile toxin (14, 22, 36). Research examining the presence of these and other genes associated with virulence in the swine STEC isolated in the present study is in progress.

Swine STEC serogroups that are potential human pathogens.

Twenty-nine and 14 strains isolated from the swine feces possessed the stx1 and stx2 genes, respectively. Thus, these strains are potential human pathogens (Table 2). Furthermore, most of the STEC serogroups that were isolated have been associated with human illnesses (15, 16, 20, 28, 33, 43, 49). For example, E. coli strains of serotypes O91:H(−), O91:H10, O91:H21, and O91:H40 have been associated with cases of bloody diarrhea and HUS (7, 28, 43). E. coli O121 has also been reported in cases of human illness, and E. coli O121:H19 was associated with an outbreak of HUS at a lake in Connecticut in 1999 (20, 31). E. coli O101 strains [H types NM, H(−), and H9] have caused bloody diarrhea and HUS (28, 44, 49). Interestingly, both the E. coli O101:H(−) and O101:H9 strains isolated in these studies possessed the stx2e variant gene. To determine the clonal relatedness of human and porcine E. coli O101 strains, Franke et al. (19) sequenced the stx2e gene of one human E. coli O101 strain (isolated from a patient with diarrhea) and four porcine E. coli O101 strains and performed virulence factor analysis and DNA fingerprinting with repetitive-element sequence-based PCR. The DNA sequences of the stx2e genes in these strains showed high identity to those in the classical STEC O139 strains that cause edema disease in swine. There was a high degree of genetic relatedness among the one human and four porcine O101 strains based on DNA fingerprinting, and the patterns of the five O101 strains did not show relatedness to those of several other STEC serogroups. However, virulence factors typically found in porcine STEC (i.e., stable toxin, labile toxin, and F107 fimbriae) and human STEC (i.e., eaeA and enterohemorragic E. coli hemolysin) were not found in the E. coli O101 strains. This result indicated that the human Stx2e-producing E. coli O101 strain, lacking typical virulence factors found in human STEC, caused illness via a different pathogenic mechanism. Furthermore, Franke et al. suggested that PCR assays targeting the stx2e variant be employed as diagnostic tools to detect and identify potential human pathogens harboring this gene.

Conclusions.

The results of this study indicate that swine may be a potential reservoir of STEC strains that cause human illness. In fact, 13.2 and 6.4% of the studied strains possessed the stx1 and stx2 genes, respectively; these genes are typically found in human STEC strains. Moreover, the majority (80%) of the STEC strains isolated from the swine feces harbored the porcine STEC stx2e variant. The extent to which swine play a role in the epidemiology of human infection, however, needs further investigation. Our studies provide information for the establishment of a database of STEC strains harbored by pigs in the United States, which is necessary for the implementation of measures for disease prevention. This database would require periodic evaluation and frequent updating when new swine STEC serotypes are discovered.

Acknowledgments

We thank Tod Stewart, Tara Lakatoz, and Orla Cloak, Eastern Regional Research Center, Agricultural Research Service, USDA, for their assistance in processing the swine fecal samples and performing the PCR assays. We also thank the group at the Richard B. Russell Agricultural Research Center, Agricultural Research Service, USDA, in Athens, Ga., for facilitating the transfer of the fecal samples.

Mention of trade names or commercial products is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.

REFERENCES

  • 1.Aarestrup, F. M., S. E. Jorsal, P. Ahrens, N. E. Jensen, and A. Meyling. 1997. Molecular characterization of Escherichia coli strains isolated from pigs with edema disease. J. Clin. Microbiol. 35:20-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alexandre, M., and V. Prado. 2003. Detection of Shiga toxin-producing Escherichia coli in food. Expert Rev. Mol. Diagn. 3:105-115. [DOI] [PubMed] [Google Scholar]
  • 3.Arthur, T. M., G. A. Barkocy-Gallagher, M. Rivera-Betancourt, and M. Koohmaraie. 2002. Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli on carcasses in commercial beef cattle processing plants. Appl. Environ. Microbiol. 68:4847-4852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bettelheim, K. A. 2003. Non-O157 verotoxin-producing Escherichia coli: a problem, paradox, and paradigm. Exp. Biol. Med. 228:333-344. [DOI] [PubMed] [Google Scholar]
  • 5.Beutin, L., D. Geier, H. Steinrück, S. Zimmermann, and F. Scheutz. 1993. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J. Clin. Microbiol. 31:2483-2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Blanco, M., J. E. Blanco, E. A. Gonzalez, A. Mora, W. Jansen, T. A. T. Gomes, L. F. Zerbini, T. Yano, A. F. P. de Castro, and J. Blanco. 1997. Genes coding for enterotoxins and vertoxins in porcine Escherichia coli strains belonging to different O:K:H serotypes: relationship with toxic phenotypes. J. Clin. Microbiol. 35:2958-2963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bonnet, R., B. Souweine, G. Gauthier, C. Rich, V. Livrelli, J. Sirot, B. Joly, and C. Forestier. 1998. Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J. Clin. Microbiol. 36:1777-1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bopp, D. J., B. D. Sauders, A. L. Waring, J. Ackelsberg, N. Dumas, E. Braun-Howland, D. Dziewulski, B. J. Wallace, M. Kelly, T. Halse, K. A. Musser, P. F. Smith, D. L. Morse, and R. J. Limberger. 2003. Detection, isolation, and molecular subtyping of Escherichia coli O157:H7 and Campylobacter jejuni associated with a large waterborne outbreak. J. Clin. Microbiol. 41:174-180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Borie, C., Z. Monreal, P. Guerrero, M. L. Sánchez, J. Martínez, C. Arellano, and V. Prado. 1997. Prevalence and characterization of enterohaemorrhagic Escherichia coli isolated from healthy cattle and pigs slaughtered in Santiago, Chile. Arch. Med. Vet. 29:205-212. [Google Scholar]
  • 10.Botteldoorn, N., M. Heyndrickx, N. Rijpens, and L. Herman. 2003. Detection and characterization of verotoxigenic Escherichia coli by a VTEC/EHEC multiplex PCR in porcine faeces and pig carcass swabs. Res. Microbiol. 154:97-104. [DOI] [PubMed] [Google Scholar]
  • 11.Bürk, C., R. Dietrich, G. Açar, M. Moravek, M. Bülte, and E. Märtlbauer. 2003. Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J. Clin. Microbiol. 41:2106-2112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Caprioli, A., A. Nigrelli, R. Gatti, M. Zavanella, A. M. Blando, F. Minelli, and G. Donelli. 1993. Characterization of verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy. Vet. Rec. 133:323-324. [DOI] [PubMed] [Google Scholar]
  • 13.Cornick, N. A., I. Matisse, J. E. Samuel, B. T. Bosworth, and H. W. Moon. 1999. Edema disease as a model for systemic disease induced by Shiga toxin-producing E. coli. Adv. Exp. Med. Biol. 473:155-161. [DOI] [PubMed] [Google Scholar]
  • 14.da Silva, A. S., G. F. Valadares, M. P. A. Penatti, B. G. Brito, and D. D. Leite. 2001. Escherichia coli strains from edema disease: O serogroups, and genes for Shiga toxin, enterotoxins, and F18 fimbriae. Vet. Microbiol. 80:227-233. [DOI] [PubMed] [Google Scholar]
  • 15.DesRosiers, A., J. M. Fairbrother, R. P. Johnson, C. Desautels, A. Letellier, and S. Quessey. 2001. Phenotypic and genotypic characterization of Escherichia coli verotoxin-producing isolates from humans and pigs. J. Food Prot. 64:1904-1911. [DOI] [PubMed] [Google Scholar]
  • 16.Eklund, M., F. Scheutz, and A. Siitonen. 2001. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J. Clin. Microbiol. 39:2829-2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Feder, I., F. M. Wallace, J. T. Gray, P. Fratamico, P. J. Fedorka-Cray, R. A. Pearce, J. E. Call, R. Perrine, and J. B. Luchansky. 2003. Isolation of Escherichia coli O157:H7 from intact colon fecal samples of swine. Emerg. Infect. Dis. 9:380-383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fegan, N., and P. Desmarchelier. 1999. Shiga toxin-producing Escherichia coli in sheep and preslaughter lambs in eastern Australia. Lett. Appl. Microbiol. 28:335-339. [DOI] [PubMed] [Google Scholar]
  • 19.Franke, S., D. Harmsen, A. Caprioli, D. Pierard, L. H. Wieler, and H. Karch. 1995. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. J. Clin. Microbiol. 33:3174-3178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Friedrich, A. W., M. Bielaszewska, W. L. Zhang, M. Pulz, T. Kuczius, A. Ammon, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84. [DOI] [PubMed] [Google Scholar]
  • 21.Frydendahl, K. 2002. Prevalence of serogroups and virulence genes in Escherichia coli associated with postweaning diarrhea and edema disease in pigs and a comparison of diagnostic approaches. Vet. Microbiol. 85:169-182. [DOI] [PubMed] [Google Scholar]
  • 22.Gannon, V. P., C. L. Gyles, and R. W. Friendship. 1988. Characteristics of verotoxigenic Escherichia coli from pigs. Can. J. Vet. Res. 52:331-337. [PMC free article] [PubMed] [Google Scholar]
  • 23.Garabal, J. I., E. A. Gonzalez, F. Vazquez, J. Blanco, M. Blanco, and J. E. Blanco. 1996. Serogroups of Escherichia coli isolated from piglets in Spain. Vet. Microbiol. 48:113-123. [DOI] [PubMed] [Google Scholar]
  • 24.Heller, L. C., C. R. Davis, K. K. Peak, D. Wingfield, A. C. Cannons, P. T. Amuso, and J. Cattani. 2003. Comparison of methods for DNA isolation from food samples for detection of Shiga toxin-producing Escherichia coli by real-time PCR. Appl. Environ. Microbiol. 69:1844-1846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Jaeger, J. L., and D. W. K. Acheson. 2000. Shiga toxin-producing Escherichia coli. Curr. Infect. Dis. Rep. 2:61-67. [DOI] [PubMed] [Google Scholar]
  • 26.Johnsen, G., Y. Wasteson, E. Heir, O. I. Berget, and H. Herikstad. 2001. Escherichia coli O157:H7 in faeces from cattle, sheep and pigs in the southwest part of Norway during 1998 and 1999. Int. J. Food Microbiol. 65:193-200. [DOI] [PubMed] [Google Scholar]
  • 27.Karch, H., M. Bielaszewska, M. Bitzan, and H. Schmidt. 1999. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn. Microbiol. Infect. Dis. 34:229-243. [DOI] [PubMed] [Google Scholar]
  • 28.Keskimäki, M., M. Saari, T. Heiskanen, and A. Siitonen. 1998. Shiga toxin-producing Escherichia coli in Finland from 1990 through 1997: prevalence and characteristics of isolates. J. Clin. Microbiol. 36:3641-3646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Leung, P. H., W. C. Yam, W. W. Ng, and J. S. Peiris. 2001. The prevalence and characterization of verotoxin-producing Escherichia coli isolated from cattle and pigs in an abattoir in Hong Kong. Epidemiol. Infect. 126:173-179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Leung, P. H. M., J. S. M. Peiris, W. W. S. Ng, R. M. Robins-Browne, K. A. Bettelheim, and W. C. Yam. 2003. A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. Appl. Environ. Microbiol. 69:7549-7553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.McCarthy, T. A., N. L. Barrett, J. L. Hadler, B. Salsbury, R. T. Howard, D. W. Dingman, C. D. Brinkman, W. F. Bibb, and M. L. Cartter. 2001. Hemolytic-uremic syndrome and Escherichia coli O121 at a lake in Connecticut. Pediatrics 108:E59. [Online.] [DOI] [PubMed] [Google Scholar]
  • 32.Meng, J., M. P. Doyle, T. Zhao, and S. Zhao. 2001. Enterohemorrhagic Escherichia coli, p. 193-214. In M. P. Doyle, L. R. Beuchat, and T. J. Montville (ed.), Food microbiology: fundamentals and frontiers, 2nd ed. ASM Press, Washington, D.C.
  • 33.Meng, J., S. Zhao, and M. P. Doyle. 1998. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans. Int. J. Food Microbiol. 45:229-235. [DOI] [PubMed] [Google Scholar]
  • 34.Meng, J., S. Zhao, M. P. Doyle, S. E. Mitchell, and S. Kresovich. 1997. A multiplex PCR for identifying Shiga-like toxin-producing Escherichia coli O157:H7. Lett. Appl. Microbiol. 24:172-176. [DOI] [PubMed] [Google Scholar]
  • 35.Muniesa, M., J. Recktenwald, M. Bielaszewska, H. Karch, and H. Schmidt. 2000. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect. Immun. 68:4850-4855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nagy, B., R. A. Wilson, and T. S. Whittam. 1999. Genetic diversity among Escherichia coli isolates carrying f18 genes from pigs with porcine postweaning diarrhea and edema disease. J. Clin. Microbiol. 37:1642-1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nakazawa, M., J. Akiba, and T. Sameshima. 1999. Swine as a potential reservoir of Shiga toxin-producing Escherichia coli O157:H7 in Japan. Emerg. Infect. Dis. 5:833-834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ochoa, T. J., and T. G. Cleary. 2003. Epidemiology and spectrum of disease of Escherichia coli O157. Curr. Opin. Infect. Dis. 16:259-263. [DOI] [PubMed] [Google Scholar]
  • 40.Osek, J. 2000. Virulence factors and genetic relatedness of Escherichia coli strains isolated from pigs with post-weaning diarrhea. Vet. Microbiol. 71:211-222. [DOI] [PubMed] [Google Scholar]
  • 41.Osek, J. 1999. Prevalence of Shiga toxin genes among Escherichia coli strains isolated from pigs. Vet. Rec. 145:557-558. [DOI] [PubMed] [Google Scholar]
  • 42.Parma, A. E., M. E. Sanz, M. R. Viñas, M. E. Cicuta, J. E. Blanco, S. I. Boehringer, M. M. Vena, W. R. Roibon, M. C. Benitez, J. Blanco, and M. Blanco. 2000. Toxigenic Escherichia coli isolated from pigs in Argentina. Vet. Microbiol. 72:269-276. [DOI] [PubMed] [Google Scholar]
  • 43.Pierard, D., D. Stevens, L. Moriau, H. Lior, and S. Lauwers. 1997. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. Clin. Microbiol. Infect. 3:531-540. [DOI] [PubMed] [Google Scholar]
  • 44.Pierard, D., L. Huyghens, S. Lauwers, and H. Lior. 1991. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin. Lancet 338:762. [DOI] [PubMed] [Google Scholar]
  • 45.Rios, M., V. Prado, M. Trucksis, C. Arellano, C. Borie, M. Alexandre, A. Fica, and M. M. Levine. 1999. Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products. J. Clin. Microbiol. 37:778-781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Schmidt, H. 2001. Shiga-toxin-converting bacteriophages. Res. Microbiol. 152:687-695. [DOI] [PubMed] [Google Scholar]
  • 47.Segura-Alvarez, M., H. Richter, F. J. Conraths, and L. Geue. 2003. Evaluation of enzyme-linked immunosorbent assays and a PCR test for detection of Shiga toxins for Shiga toxin-producing Escherichia coli in cattle herds. J. Clin. Microbiol. 41:5760-5763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sharma, V. K. 2002. Detection and quantitation of enterohemorrhagic Escherichia coli O157, O111, and O26 in beef and bovine feces by real-time polymerase chain reaction. J. Food Prot. 65:1371-1380. [DOI] [PubMed] [Google Scholar]
  • 49.Thomas, A., T. Cheasty, H. Chart, and B. Rowe. 1994. Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 13:1074-1076. [DOI] [PubMed] [Google Scholar]
  • 49a.U.S. Department of Agriculture. 2001. Part I. Reference of swine health and management in the United States, 2000, National Animal Health Monitoring System. Publication no. 338.0801. USDA Centers for Epidemiology and Animal Health, Fort Collins, Colo.
  • 50.Vernozy-Rozand, C. 1997. Detection of Escherichia coli O157:H7 and other verocytotoxin-producing E. coli (VTEC) in food. J. Appl. Microbiol. 82:537-551. [DOI] [PubMed] [Google Scholar]
  • 51.World Health Organization. 1999. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC): report of a WHO scientific working group meeting, Berlin, Germany, 23-26 June 1998. [Online.] http://www.who.int/emc-documents/zoonoses/docs/whocsraph988.html/shigaindex.html.

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES